Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding DE:GN0M?
Track your performance easily
DE:GN0M Price & Analysis
GN0M ETF Chart & Stats
Day’s Range― - ―
52-Week Range€6.20 - €8.13
Previous Close€6.68
VolumeN/A
Average Volume (3M)9.65K
AUM9.35M
NAV6.85
Expense Ratio0.60%
Holdings Count42
Beta1.04
Inception DateNov 02, 2021
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. Volume9,654
AlphaN/A
Global X Genomics & Biotechnology UCITS ETF (GN0M) Fund Flow Chart
Global X Genomics & Biotechnology UCITS ETF (GN0M) 1 year Net Flows: €3M
GN0M ETF News
GN0M ETF FAQ
What was DE:GN0M’s price range in the past 12 months?
DE:GN0M lowest ETF price was €6.20 and its highest was €8.13 in the past 12 months.
What is the AUM of DE:GN0M?
As of Dec 19, 2024 The AUM of DE:GN0M is 9.35M.
Is DE:GN0M overvalued?
According to Wall Street analysts DE:GN0M’s price is currently Undervalued.
Does DE:GN0M pay dividends?
DE:GN0M does not currently pay dividends.
How many shares outstanding does DE:GN0M have?
Currently, no data Available
Which hedge fund is a major shareholder of DE:GN0M?
Currently, no hedge funds are holding shares in DE:GN0M
GN0M ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Natera Inc.
5.82%
Veracyte Inc
5.26%
Qiagen
4.60%
Bio-Techne
4.50%
Biontech Se Sponsored Adr
4.39%
Agilent Technologies
4.36%
Arrowhead Pharmaceuticals, Inc.
4.27%
Illumina
4.10%
Biomarin Pharmaceutical Inc.
4.07%
Sarepta Therapeutics Inc.
4.02%
Total45.39%
ETF Description
Global X Genomics & Biotechnology UCITS ETF
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index